Sunday, February 22, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Most Health Journalists Freelance

What does that mean for health news?

Jay K Joshi by Jay K Joshi
May 28, 2024
in Trends
0
Most Health Journalists Freelance

Tyler Franta

Journalists are a lot like physicians. Both enter their respective fields with a sense of duty only to find both fields laden with layers of bureaucracy. But there’s a key difference.

Medicine is going through another phase of consolidation, much like what we saw in the 1980s. Journalism, on the other hand, is going through an unprecedented era of decentralization. Now, according to the Association of Healthcare Journalists, more health journalists are freelancers than are employed, salaried journalists. This is a good thing.

Freelance journalists are freer to write stories that appeal to them. Health media outlets, now more reliant on freelance journalists, will select stories they believe might resonate more strongly with the public. The market of ideas ultimately wins. When journalists are employed, they’re more beholden to the editorial biases of their employers. Whether or not these biases are consciously imposed is irrelevant. They’re a natural outcrop of any bureaucratic structure.

It’s a common thread lining both medicine and journalism. It’s just as damaging to both fields. Many see the rise in freelance journalism as a negative bellwether for journalism. It’s quite the opposite. With smaller media outlets and more independent journalists, the market of ideas has less shackles. Ideas can flow across more media outlets and through more platforms – some tradition and some more innovative.

In recent months, some of the most esteemed media outlets underwent job cuts. Some of the more savvy journalists didn’t miss a beat. One day they’re writing in their featured column. The next day they’re writing on their own media platform. Other than the veneer of old-timey newspaper establishment, the difference is negligible. The ideas still shine through: Sometimes even more so.

Free markets are decentralized. Journalism is the market of ideas. The more decentralized, the more ideas can spread. Health journalists should see the movement toward freelance journalism as a sign that the market force is the idea, or more plainly stated, the content itself. Before, health journalism was relegated to a particular section of newspapers. Only the most high profile health news stories became mainstream topics.

Now the funnel has been blown wide open. The public now demands more wide-ranging stories and more diverse perspectives on those stories. The market is saturated with cookie-cutter stories about basic health news or trite pieces on clinical do’s and don’ts.

The public wants something more substantial. In the post-pandemic world of healthcare, the public craves contrarian perspectives. They’re predisposed to disbelieve, so when they see a novel take on something, they’re more likely to pay attention. That should be music to the ears of any savvy freelance health journalist. After all, the relationship between readers and writers is symbiotic. One cannot exist without the other.

All of which is to say: Health journalists should prioritize novel ideas and perspectives more than ever before. The bureaucratic infrastructure of journalism, the political dynamism that defines the editorial room, has never been weaker.

Rather than try to pitch the same ideas to the same media outlets – now as a freelancer instead of as a former employee – is no longer necessary. The public wants new takes because they find those takes more trustworthy.

As a physician with a growing patient population, I sense a pervasive distrust with the familiar. It’s contrary to what every behavioral economist would tell you. Normally, what’s familiar is what’s favored. Not in modern medicine. Novelty is preferred, particularly among my patients.

What a physician sees in a patient often reflects what a health journalist sees across swaths of patient populations. Healthcare is a fractal. The trends found at an individual level often replicate at a larger level. Health journalism is reflective of the broader ethos seen among individual patients in the doctor’s office.

So when I see my patients challenge the paradigm of established medicine, I sense the public is looking for novel perspectives on healthcare. Freelance health journalists should see this as their opportunity to tap into a new, fast-growing sector of the reading public. The market is wide open. May the best ideas win.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • The Staffing Equation That Doesn’t Balance

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy